World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
63
Citations
15786
World Ranking
2710
National Ranking
1091

Overview

Shinichi Oka is affiliated with Rutgers, The State University of New Jersey in the United States. Their research spans multiple areas within medicine with a primary focus on infectious diseases, immunology, and microbiology.

The scientist has contributed extensively to the fields of HIV research and treatment, including HIV/AIDS interventions and drug development. Their work also covers HIV-related health complications, drug use and sexual risk factors associated with HIV, immune cell function and interaction, and hepatitis C virus research.

Key areas of study include:

  • Medicine
  • Immunology and Microbiology

More specific subfields addressed in their research are:

  • Infectious Diseases
  • Epidemiology
  • Virology
  • Immunology
  • Surgery

Frequent publication venues for their work include:

  • Global Health & Medicine
  • Scientific Reports
  • Journal of Infection and Chemotherapy
  • Journal of Virology
  • bioRxiv (Cold Spring Harbor Laboratory)

Some of their recent papers include:

  • Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection, 2020, New England Journal of Medicine
  • Metagenomic Identification of Microbial Signatures Predicting Pancreatic Cancer From a Multinational Study, 2022, Gastroenterology
  • Long-acting cabotegravir plus rilpivirine for treatment in adults with HIV-1 infection: 96-week results of the randomised, open-label, phase 3 FLAIR study, 2021, The Lancet HIV
  • Population-level Metagenomics Uncovers Distinct Effects of Multiple Medications on the Human Gut Microbiome, 2022, Gastroenterology
  • Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials, 2020, JAIDS Journal of Acquired Immune Deficiency Syndromes

Frequently collaborating coauthors associated with Shinichi Oka include:

  • Hiroyuki Gatanaga
  • Daisuke Mizushima
  • Misao Takano
  • Yoshimi Kikuchi
  • Kôji Watanabe

Best Publications

  • Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials

    Paul E Sax;David Wohl;Michael T Yin;Frank Post

  • Adaptation of HIV-1 to human leukocyte antigen class I

    Y. Kawashima;K. Pfafferott;J. Frater;P. Matthews

  • Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection

    Chloe Orkin;Keikawus Arasteh;Miguel Górgolas Hernández-Mora;Vadim Pokrovsky

  • Homozygous CYP2B6 *6 (Q172H and K262R) correlates with high plasma efavirenz concentrations in HIV-1 patients treated with standard efavirenz-containing regimens.

    Kiyoto Tsuchiya;Hiroyuki Gatanaga;Natsuo Tachikawa;Katsuji Teruya

  • Successful Efavirenz Dose Reduction in HIV Type 1-Infected Individuals with Cytochrome P450 2B6 *6 and *26

    Hiroyuki Gatanaga;Tsunefusa Hayashida;Kiyoto Tsuchiya;Munehiro Yoshino

  • Metagenomic identification of microbial signatures predicting pancreatic cancer from a multinational study.

    Unknown

  • Assessment, Diagnosis, and Treatment of HIV-Associated Neurocognitive Disorder: A Consensus Report of the Mind Exchange Program

    Andrea Antinori;Gabriele Arendt;Igor Grant

  • Brief Report: Randomized, Double-Blind Comparison of Tenofovir Alafenamide (TAF) vs Tenofovir Disoproxil Fumarate (TDF), Each Coformulated With Elvitegravir, Cobicistat, and Emtricitabine (E/C/F) for Initial HIV-1 Treatment: Week 144 Results.

    José R Arribas;Melanie Thompson;Paul E Sax;Bernhard Haas

  • Induction of IFN-λ3 as an additional effect of nucleotide, not nucleoside, analogues: a new potential target for HBV infection.

    Kazumoto Murata;Mai Asano;Akihiro Matsumoto;Masaya Sugiyama

  • Population-level metagenomics uncovers distinct effects of multiple medications on the human gut microbiome.

    Unknown

  • HLA-Cw8 primarily associated with hypersensitivity to nevirapine.

    Hiroyuki Gatanaga;Hirohisa Yazaki;Junko Tanuma;Miwako Honda

  • Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries.

    Dorita Avila;Keri N. Althoff;Catrina Mugglin;Kara Wools-Kaloustian

  • Evaluation of acridinium-ester-labeled DNA probes for identification of Mycobacterium tuberculosis and Mycobacterium avium-Mycobacterium intracellulare complex in culture.

    M Goto;S Oka;K Okuzumi;S Kimura

  • Long-acting cabotegravir plus rilpivirine for treatment in adults with HIV-1 infection: 96-week results of the randomised, open-label, phase 3 FLAIR study

    Chloe Orkin;Shinichi Oka;Patrick Philibert;Cynthia Brinson

  • Outbreak of Pneumocystis jiroveci pneumonia in renal transplant recipients: P. jiroveci is contagious to the susceptible host.

    Hirohisa Yazaki;Norihiko Goto;Kazuharu Uchida;Takaaki Kobayashi

  • Functional Expression of the Chemokine Receptor CCR5 on Virus Epitope-Specific Memory and Effector CD8+ T Cells

    Katsuhiko Fukada;Yuji Sobao;Hiroko Tomiyama;Shinichi Oka

  • Novel Conserved-region T-cell Mosaic Vaccine With High Global HIV-1 Coverage Is Recognized by Protective Responses in Untreated Infection

    Beatrice Ondondo;Hayato Murakoshi;Genevieve Clutton;Genevieve Clutton;Sultan Abdul-Jawad

  • Impaired fatty acid utilization in thioredoxin binding protein-2 (TBP-2)-deficient mice: a unique animal model of Reye syndrome

    Shinichi Oka;Wenrui Liu;Hiroshi Masutani;Hiromi Hirata

  • Extensive gut virome variation and its associations with host and environmental factors in a population-level cohort

    Unknown

  • (1-->3) beta-D-glucan as a quantitative serological marker for Pneumocystis carinii pneumonia.

    A Yasuoka;N Tachikawa;K Shimada;S Kimura

  • Impact of small body weight on tenofovir-associated renal dysfunction in HIV-infected patients: a retrospective cohort study of Japanese patients

    Takeshi Nishijima;Hirokazu Komatsu;Hiroyuki Gatanaga;Takahiro Aoki

  • Urinary beta2-microglobulin as a possible sensitive marker for renal injury caused by tenofovir disoproxil fumarate.

    Hiroyuki Gatanaga;Natsuo Tachikawa;Yoshimi Kikuchi;Katsuji Teruya

  • Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials.

    Giuliano Rizzardini;Edgar T. Overton;Chloe Orkin;Susan Swindells

  • Polymorphism in the Interleukin-4 Promoter Affects Acquisition of Human Immunodeficiency Virus Type 1 Syncytium-Inducing Phenotype

    Emi E. Nakayama;Yoshihiko Hoshino;Xiaomi Xin;Huanliang Liu

  • Rapid and simple phenotypic assay for drug susceptibility of human immunodeficiency virus type 1 using CCR5-expressing HeLa/CD4(+) cell clone 1-10 (MAGIC-5).

    Atsuko Hachiya;Saori Aizawa-Matsuoka;Mari Tanaka;Yukiko Takahashi

Frequent Co-Authors

Satoshi Kimura
Satoshi Kimura University of Tokyo
Hideo Shinagawa
Hideo Shinagawa BioAcademia
Shigeru Kohno
Shigeru Kohno Nagasaki University
Aikichi Iwamoto
Aikichi Iwamoto Japan Agency for Medical Research and Development
Masafumi Takiguchi
Masafumi Takiguchi Kumamoto University
Hiroyuki Gatanaga
Hiroyuki Gatanaga Kumamoto University
Tomáš Hanke
Tomáš Hanke University of Oxford
Akio Adachi
Akio Adachi Kansai Medical University
Shigeo Mori
Shigeo Mori University of Tokyo
Yoshikazu Nakamura
Yoshikazu Nakamura University of Tokyo

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in microbiology, exploring related online healthcare programs can broaden career opportunities beyond the lab. Many of these programs offer flexible schedules, making it easier to balance studies and work. If you're considering public health, some of the best easiest MPH online programs to get into provide a streamlined path to advancing your skills without overly competitive admissions.

Understanding salary expectations is crucial when planning your career. For example, exploring the child specialist salary can help you assess if this specialized pathway aligns with your financial goals. These specialists often benefit from strong job growth and rewarding work environments.

Additionally, individuals with unique backgrounds should know that there are inclusive degree options. The best degrees for felons can provide a fresh start and open doors to stable careers in healthcare and science, reinforcing that higher education is accessible to many.

Overall, combining microbiology with these online degrees and understanding diverse career pathways can help you build a versatile and rewarding professional life in the healthcare and science sectors.

Best Scientists Citing Shinichi Oka

Trending Scientists